Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BeiGene Ltd (NASDAQ:BGNE)

81.51
Delayed Data
As of Oct 23
 -2.52 / -3.00%
Today’s Change
26.43
Today|||52-Week Range
118.95
+168.48%
Year-to-Date
No recent news for BeiGene Ltd.

Today’s Trading

Previous close84.03
Today’s open84.37
Day’s range80.13 - 85.07
Volume402,242
Average volume (3 months)294,631
Market cap$3.6B
Dividend yield--
Data as of 10/23/2017

Growth & Valuation

Earnings growth (last year)+42.42%
Earnings growth (this year)-32.97%
Earnings growth (next 5 years)--
Revenue growth (last year)-87.89%
P/E ratioNM
Price/Sales883.21
Price/Book9.44

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...+0.02+0.50%
OASMOasmia Pharmaceutica...-0.12-12.63%
TEVATeva Pharmaceutical-0.36-2.42%
Data as of 10/23/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$1.1M
Annual profit (last year)-$118.9M
Net profit margin-11,141.78%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John V. Oyler
Head-
Operations
Maggie Liu
Corporate headquarters
Beijing, Beijing

Forecasts